The effect of short-term treatment with interferon β 1a on acute experimental allergic encephalomyelitis

Folia Neuropathologica

Volumn 39, Issue 2, 2001, Pages 91-93

  Wender, Mieczysław ^a   Michalak, Sławomir ^a   Wygladalska Jernas, Halina ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Cytokines; EAE; Interferon beta

Indexed keywords

BETA1A INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFECT; DRUG INHIBITION; FEMALE; HISTOLOGY; IMMUNOCYTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SHORT COURSE THERAPY;

EID: 0035758064     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS
2. Neutralizing antibodies to interferon β 1a and interferon β 1b in MS patients are cross reactive
3. In vivo effects of interferon β 1a on immunosuppressive cytokines in multiple sclerosis
4. The length of treatment of determines whether IFN beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats
5. Discontinuation of treatment with IFN beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats
6. Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion